WASHINGTON, D.C.: A drug with the potential to slow Alzheimer’s so effectively sufferers never experience memory loss has been hailed as a “breakthrough”.
Scientists hope the pioneering therapy, which is in final stage trials, will be made widely available to patients within four to five years.
Dr Emer MacSweeney a world leading expert on Alzheimer’s who is helping enrol patients into the trial said: “This potentially marks a major turning point in Alzheimer’s treatment.
“For the first time these final phase trials give individuals an opportunity right now to potentially change their future by slowing progression of their disease and symptoms…